【快讯】退市新规实施，超百家个股面临退市风险 2025年退市新规已正式实施，目前已有超过百家个股收到警示函或公布存在退市风险。新规明确了财务类、交易类和规范类退市指标，旨在清除市场垃圾，促进A股健康发展。 财务类退市指标方面，沪深主板公司连续两年营收低于3亿元且亏损将被警示，第三年未达标则直接退市。科创板和创业板保持原有标准，财务造假金额达到一定规模或连续三年造假将强制退市。 交易类退市指标包括总市值和股价，主板公司市值连续20个低于5亿元或实际低于3亿元将退市，科创板和创业板公司市值连续20个低于3亿元也将退市。

股价连续20个低于面值同样面临退市风险。 规范类退市指标涉及信息披露违规、公司治理问题及其他违法行为，如重大环境违法、安全事故等，均可能导致公司退市。 上周已有超过百家个股收到行政处罚、监管函、警示函或面临退市风险，包括思科瑞、*ST中程、清水源等。专家提醒，2025年将是退市大年，投资者应避免触碰问题公司和ST个股，关注市场趋势，谨慎入市。 

股票名称 ["思科瑞","*ST中程","清水源","新开源","*ST普利","ST英飞拓","戈碧迦","华英证券","广发证券","杭州园林","绿亨科技","博迁新材","ST元成","多利科技","九安医疗","ST宇顺","华扬联众","返利科技","菲林格尔","ST步森","天微电子","先达股份","汇宇制药","ST元成","多利科技","沐邦高科","华嵘控股","亚太实业","波导股份","青海华鼎","海南椰岛","返利科技","东晶电子","天微电子","双成药业","亚振家居","国华网安","ST惠程","兰州黄河","ST元成","*ST大药","铖昌科技","国新文化","川大智胜","*ST大药","ST聆达","新研股份","ST三圣","ST步森","*ST大药","中交地产","四通股份","海源复材","四环生物","金发拉比","建艺集团","辉丰股份","立航科技","高斯贝尔","中科云网","*ST美讯","ST起步","威尔泰","星光农机","长药控股","庚星股份","*ST大药","中基健康","大晟文化","*ST金科","太和水","岩石股份","ST交投","荣丰控股","清研环境","创兴资源","原尚股份","南国置业","传智教育","宝塔实业","ST恒久","金刚光伏","东易日盛","ST沪科","*ST文投","*ST中迪","*ST嘉寓","*ST宁科","*ST信通","*ST信通","*ST和展","*ST摩登","*ST仁东","ST中润","ST龙津","ST景峰","*ST大药","*ST信通","*ST傲农","*ST大药","*ST卓朗","*ST工智","*ST鹏博","*ST信通","*ST东园","*ST天创","*ST大药","*ST海越","*ST同洲","*ST九有","*ST科新","ST金时","ST摩登","ST龙宇"]板块名称 ["A股"]退市新规、退市风险、财务造假看多看空（看空） 2025年退市新规已经开始实施，超过百家个股收到警示函或公布有退市风险，财务造假和业绩不佳的公司面临退市风险，市场将清除垃圾公司，A股可能面临较大压力。退市新规 超百家收到退市风险（名单）和讯自选股写手风险提示：以上内容仅作为作者或者嘉宾的观点，不代表和讯的任何立场，不构成与和讯相关的任何投资建议。在作出任何投资决定前，投资者应根据自身情况考虑投资产品相关的风险因素，并于需要时咨询专业投资顾问意见。和讯竭力但不能证实上述内容的真实性、准确性和原创性，对此和讯不做任何保证和承诺。